Early intervention is key

Empowering patients to better protect themselves from severe allergic reactions that could lead to anaphylaxis. Anaphylaxis is a severe, life-threatening allergic reaction that could be fatal if not treated immediately.


An Alternative to Epinephrine Auto-Injectors

Successful dry powder inhalation

We are developing an epinephrine dry powder inhaler that for patients and their families could transform the treatment of allergic reactions potentially leading to anaphylaxis.

User friendly

Some people may take a “watch and wait” approach to using an auto-injector. 

Consistent Delivery

ARS-1 is uniquely formulated with an absorption enhancing technology that has shown a comparable rate of epinephrine absorption to intramuscular injection with less risk of variability.


There is a fear of needles and stigma that leads to an unwillingness to use an auto-injector in public to treat severe allergic reactions. For parents or guardians, injecting a child may also be traumatic.


Small enough to carry in a pocket or purse anytime, anywhere.